Mapping routine measles vaccination in low- and middle-income countries

The safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)1,2,3,4. Globally comparabl...

Full description

Bibliographic Details
Main Authors: Sbarra, AN, Rolfe, S, Nguyen, JQ, Lacey, BWH
Other Authors: Local Burden of Disease Vaccine Coverage Collaborators
Format: Journal article
Language:English
Published: Springer Nature 2020
_version_ 1797105197646872576
author Sbarra, AN
Rolfe, S
Nguyen, JQ
Lacey, BWH
author2 Local Burden of Disease Vaccine Coverage Collaborators
author_facet Local Burden of Disease Vaccine Coverage Collaborators
Sbarra, AN
Rolfe, S
Nguyen, JQ
Lacey, BWH
author_sort Sbarra, AN
collection OXFORD
description The safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)1,2,3,4. Globally comparable, annual, local estimates of routine first-dose measles-containing vaccine (MCV1) coverage are critical for understanding geographically precise immunity patterns, progress towards the targets of the Global Vaccine Action Plan (GVAP), and high-risk areas amid disruptions to vaccination programmes caused by coronavirus disease 2019 (COVID-19)5,6,7,8. Here we generated annual estimates of routine childhood MCV1 coverage at 5 × 5-km2 pixel and second administrative levels from 2000 to 2019 in 101 LMICs, quantified geographical inequality and assessed vaccination status by geographical remoteness. After widespread MCV1 gains from 2000 to 2010, coverage regressed in more than half of the districts between 2010 and 2019, leaving many LMICs far from the GVAP goal of 80% coverage in all districts by 2019. MCV1 coverage was lower in rural than in urban locations, although a larger proportion of unvaccinated children overall lived in urban locations; strategies to provide essential vaccination services should address both geographical contexts. These results provide a tool for decision-makers to strengthen routine MCV1 immunization programmes and provide equitable disease protection for all children.
first_indexed 2024-03-07T06:44:02Z
format Journal article
id oxford-uuid:fa445419-6c26-4a00-a762-91842360968c
institution University of Oxford
language English
last_indexed 2024-03-07T06:44:02Z
publishDate 2020
publisher Springer Nature
record_format dspace
spelling oxford-uuid:fa445419-6c26-4a00-a762-91842360968c2022-03-27T13:04:26ZMapping routine measles vaccination in low- and middle-income countriesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fa445419-6c26-4a00-a762-91842360968cEnglishSymplectic ElementsSpringer Nature2020Sbarra, ANRolfe, SNguyen, JQLacey, BWHLocal Burden of Disease Vaccine Coverage CollaboratorsThe safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)1,2,3,4. Globally comparable, annual, local estimates of routine first-dose measles-containing vaccine (MCV1) coverage are critical for understanding geographically precise immunity patterns, progress towards the targets of the Global Vaccine Action Plan (GVAP), and high-risk areas amid disruptions to vaccination programmes caused by coronavirus disease 2019 (COVID-19)5,6,7,8. Here we generated annual estimates of routine childhood MCV1 coverage at 5 × 5-km2 pixel and second administrative levels from 2000 to 2019 in 101 LMICs, quantified geographical inequality and assessed vaccination status by geographical remoteness. After widespread MCV1 gains from 2000 to 2010, coverage regressed in more than half of the districts between 2010 and 2019, leaving many LMICs far from the GVAP goal of 80% coverage in all districts by 2019. MCV1 coverage was lower in rural than in urban locations, although a larger proportion of unvaccinated children overall lived in urban locations; strategies to provide essential vaccination services should address both geographical contexts. These results provide a tool for decision-makers to strengthen routine MCV1 immunization programmes and provide equitable disease protection for all children.
spellingShingle Sbarra, AN
Rolfe, S
Nguyen, JQ
Lacey, BWH
Mapping routine measles vaccination in low- and middle-income countries
title Mapping routine measles vaccination in low- and middle-income countries
title_full Mapping routine measles vaccination in low- and middle-income countries
title_fullStr Mapping routine measles vaccination in low- and middle-income countries
title_full_unstemmed Mapping routine measles vaccination in low- and middle-income countries
title_short Mapping routine measles vaccination in low- and middle-income countries
title_sort mapping routine measles vaccination in low and middle income countries
work_keys_str_mv AT sbarraan mappingroutinemeaslesvaccinationinlowandmiddleincomecountries
AT rolfes mappingroutinemeaslesvaccinationinlowandmiddleincomecountries
AT nguyenjq mappingroutinemeaslesvaccinationinlowandmiddleincomecountries
AT laceybwh mappingroutinemeaslesvaccinationinlowandmiddleincomecountries